Atea Pharmaceuticals shares owned by Vanguard Group
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14M | 4.7M | 2.90 |
| 2025-06-30 | $18M | 4.9M | 3.60 |
| 2025-03-31 | $14M | 4.7M | 2.99 |
| 2024-12-31 | $16M | 4.7M | 3.35 |
| 2024-09-30 | $16M | 4.9M | 3.35 |
| 2024-06-30 | $16M | 4.7M | 3.31 |
| 2024-03-31 | $19M | 4.7M | 4.04 |
| 2023-12-31 | $14M | 4.6M | 3.05 |
| 2023-09-30 | $14M | 4.6M | 3.00 |
| 2023-06-30 | $17M | 4.5M | 3.74 |
| 2023-03-31 | $15M | 4.6M | 3.35 |
| 2022-12-31 | $29M | 6.1M | 4.81 |
| 2022-06-30 | $51M | 7.2M | 7.10 |
| 2022-03-31 | $49M | 6.7M | 7.22 |
| 2021-09-30 | $182M | 5.2M | 35.06 |
| 2021-06-30 | $97M | 4.5M | 21.48 |
| 2021-03-31 | $68M | 1.1M | 61.75 |
| 2020-12-31 | $45M | 1.1M | 41.77 |